Results for Tumor Detection

Dr. Balis's research focuses on the clinical pharmacology of anticancer drugs, new drug development, and clinical trial design and endpoints. He studies the pharmacokinetics and pharmacodynamics of anticancer drugs and has applied pharmacological principles to clinical trial design and clinical drug development. He is developing new biomarkers to serve as surrogate endpoints of drug toxicity or efficacy in clinical trials.

Dr. Chen's research focuses on traumatic brain injury (TBI), multimodal neuromonitoring, and neurovascular disorders. She is interested in non-invasive forms of neuromonitoring thus leading to research efforts identifying reliable non-invasive methods for detecting intracranial hypertension in multiple disease processes including TBI and craniosynostosis.

Dr. Diskin's research is focused on translational genomics in childhood cancers. Her laboratory seeks to identify the genetic basis of childhood cancers by combining quantitative computational methods with rigorous "wet-lab" experimental approaches. In parallel, she has developed, and is applying, a proteogenomic approach to identify novel immunotherapeutic targets for high-risk and relapsed pediatric malignancies.

Dr. Sultan is a physician and scientist with a focus on advanced ultrasound imaging techniques.